News

New findings indicate the potential of Ruxolitinib as an effective treatment for steroid-refractory acute graft-versus-host disease.

Uptake of in vitro fertilisation and intrauterine insemination has increased among women in Europe, according to data presented at the ESHRE 40th annual meeting.

New research presented at ESHRE highlights significant social disparities in achieving live births following assisted reproductive technology treatment.

Results presented at EULAR 2024, show reductions in DAS28 scores among rheumatoid arthritis patients following a plant-based, whole-food diet, exercise, and stress management regime.

Researchers presented novel findings on the potential utility of the blood interferon signature in diagnosing and stratifying paediatric Sjögren’s disease.

Research presented at ESHRE 2024 reveals higher risks of severe maternal morbidity and adverse pregnancy outcomes for gestational carriers compared to natural and IVF conceptions.

Pioneering research presented at the ESHRE 40th Annual Meeting suggests that exposure to fine particulate matter before the retrieval of oocytes during IVF can impact the odds of achieving a life birth.

A study has highlighted the clinical significance of circulating tumour cells in the blood of multiple myeloma patients, proposing a new cutoff that could enhance treatment outcomes.